Adedokun KA, Imodoye SO, Bello IO, Lanihun A, Bello IO (2023a) Therapeutic potentials of medicinal plants for the treatment of cancer and significance of computational tools in anticancer drug discovery, 1st edn. Elsevier, Amsterdam

Google Scholar 

Adedokun KA, Oluogun WA, Oyenike MA, Imodoye SO, Yunus LA, Lasisi IA, Bello IO, Kamorudeen RT, Adekola SA (2023b) Expression patterns of ER, PR, Her-2/neu and p53 in association with Nottingham tumor grade: a retrospective hospital-based study. Sultan Qaboos Univ Med J. https://doi.org/10.18295/squmj.7.2023.044

Article  PubMed  PubMed Central  Google Scholar 

Adedokun AK, Imodoye SO, Yahaya ZS, Oyeyemi IT, Bello IO, Adeyemo-Imodoye MT, Sanusi MA, Kamorudeen RT (2024) Nanodelivery of polyphenols as nutraceuticals in anticancer interventions. In: Rudrapal M (ed) Polyphenols: food, nutraceutical, and nanotherapeutic applications, 1st edn. Wiley, Hoboken. https://doi.org/10.1002/9781394188864.ch10

Chapter  Google Scholar 

Aderetti DA, HiraMolenaar VVVRJ, Van Noorden CJF (2018) The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma. Biochim Biophys Acta Rev Cancer 1869(2):346–354. https://doi.org/10.1016/j.bbcan.2018.04.008

Article  CAS  PubMed  Google Scholar 

Albini A, Bruno A, Gallo C, Pajardi G, Noonan DM, Dallaglio K (2015) Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity. Connect Tissue Res 56(5):414–425. https://doi.org/10.3109/03008207.2015.1066780

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aldous AR, Dong JZ (2018) Personalized neoantigen vaccines: a new approach to cancer immunotherapy. Bioorg Med Chemi 26(10):2842–2849. https://doi.org/10.1016/j.bmc.2017.10.021

Article  CAS  Google Scholar 

Asp M, Salmén F, Ståhl PL, Vickovic S, Felldin U, Löfling M, Fernandez Navarro J, Maaskola J, Eriksson MJ, Persson B, Corbascio M (2017) Spatial detection of fetal marker genes expressed at low level in adult human heart tissue. Sci Rep 7(1):12941. https://doi.org/10.1038/s41598-017-13462-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Assidicky R, Tokat UM, Tarman IO, Saatci O, Ersan PG, Raza U, Ogul H, Riazalhosseini Y, Can T, Sahin O (2022) Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer. Breast Cancer Res Treat 193(2):331–348. https://doi.org/10.1007/s10549-022-06569-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18(1):59. https://doi.org/10.1186/s12964-020-0530-4

Article  PubMed  PubMed Central  Google Scholar 

Belli C, Trapani D, Viale G, D’Amico P, Duso BA, Della Vigna P, Orsi F, Curigliano G (2018) Targeting the microenvironment in solid tumors. Cancer Treat Rev 65:22–32. https://doi.org/10.1016/j.ctrv.2018.02.004

Article  CAS  PubMed  Google Scholar 

Berglund E, Maaskola J, Schultz N, Friedrich S, Marklund M, Bergenstråhle J, Tarish F, Tanoglidi A, Vickovic S, Larsson L, Salmen F (2018) Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nat Commun 9(1):2419. https://doi.org/10.1038/s41467-018-04724-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blass E, Ott PA (2021) Advances in the development of personalized neoantigen-based therapeutic cancer vaccines. Nat Rev Clin Oncol 18(4):215–229. https://doi.org/10.1038/s41571-020-00460-2

Article  PubMed  PubMed Central  Google Scholar 

Boudreau JE, Bonehill A, Thielemans K, Wan Y (2011) Engineering dendritic cells to enhance cancer immunotherapy. Mol Ther 19(5):841–853. https://doi.org/10.1038/mt.2011.57

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cajal SR, Sesé M, Capdevilla C, Aasen T, Mattos-Arruda LD, Diaz-Cano SJ, Hernandez-Losa CJ (2020) Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med 98:161–177. https://doi.org/10.1007/s00109-020-01874-2

Article  Google Scholar 

Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA, Morsberger LA, Latimer C, McLaren S, Lin ML, McBride DJ (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467(7319):1109–1113. https://doi.org/10.1038/nature09460

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castle JC, Kreiter S, Diekmann J, Löwer M, Van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M (2012) Exploiting the mutanome for tumor vaccination. Cancer Res 72(5):1081–1091. https://doi.org/10.1158/0008-5472.Can-11-3722

Article  CAS  Google Scholar 

Cazet AS, Hui MN, Elsworth BL, Wu SZ, Roden D, Chan CL, Skhinas JN, Collot R, Yang J, Harvey K, Johan MZ (2018) Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. Nat Commun 9(1):2897. https://doi.org/10.1038/s41467-018-05220-6

Article  CAS  PubMed Central  Google Scholar 

Chapouly C, Guimbal S, Hollier P-L, Renault M-A (2019) Role of hedgehog signaling in vasculature development, differentiation, and maintenance. Int J Mol Sci 20(12):3076

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA, Ling TY, Yu SL, Yuan SS, Louisa Chen YJ, Lin CY, Pan SH (2014) Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun 5(1):3472. https://doi.org/10.1038/ncomms4472

Article  CAS  Google Scholar 

Chen Y, Wen H, Zhou C, Su Q, Lin Y, Xie Y, Huang Y, Qiu Q, Lin J, Huang X, Tan W (2019) TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells. Exp Cell Res 378(1):41–50. https://doi.org/10.1016/j.yexcr.2019.03.005

Article  CAS  PubMed  Google Scholar 

Chen Y, Jin H, Song Y, Huang T, Cao J, Tang Q, Zou Z (2021) Targeting tumor-associated macrophages: a potential treatment for solid tumors. J Cell Physiol 236(5):3445–3465. https://doi.org/10.1002/jcp.30139

Article  CAS  PubMed  Google Scholar 

Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, Bonneau C (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33:463–479. https://doi.org/10.1016/j.ccell.2018.01.011

Article  CAS  PubMed  Google Scholar 

Craig DJ, Bailey MM, Noe OB, Williams KK, Stanbery L, Hamouda DM, Nemunaitis JJ (2022) Subclonal landscape of cancer drives resistance to immune therapy. Cancer Treat Res Commun 30:100507. https://doi.org/10.1016/j.ctarc.2021.100507

Article  PubMed  Google Scholar 

Cui X, Liu R, Duan L, Cao D, Zhang Q, Zhang A (2021) CAR-T therapy: prospects in targeting cancer stem cells. J Cell Mol Med 25(21):9891–9904. https://doi.org/10.1111/jcmm.16939

Article  PubMed  PubMed Central  Google Scholar 

Dawson MAKT, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150(1):12–27. https://doi.org/10.1016/j.cell.2012.06.013

Article  CAS  PubMed  Google Scholar 

Dianat-Moghadam H, Heidarifard M, Jahanban-Esfahlan R, Panahi Y, Hamishehkar H, Pouremamali F, Rahbarghazi R, Nouri M (2018) Cancer stem cells emanated therapy resistance: implications for liposomal drug delivery systems. J Control Release 288:62–83. https://doi.org/10.1016/j.jconrel.2018.08.043

Article  CAS  PubMed  Google Scholar 

Dijkstra KK, Wu Y, Swanton C (2023) The effects of clonal heterogeneity on cancer immunosurveillance. Annu Rev Cancer Biol 7(1):131–147. https://doi.org/10.1146/annurev-cancerbio-061521-101910

Article  Google Scholar 

DiMarco AV, Qin X, McKinney BJ, Garcia NM, Van Alsten SC, Mendes EA, Force J, Hanks BA, Troester MA, Owzar K, Xie J (2022) APOBEC mutagenesis inhibits breast cancer growth through induction of T cell-mediated antitumor immune responses. Cancer Immunol Res 10(1):70–86. https://doi.org/10.1158/2326-6066.Cir-21-0146

Article  CAS  PubMed  Google Scholar 

Donada M, Bonin S, Barbazza R, Pettirosso D, Stanta G (2013) Management of stage II colon cancer—the use of molecular biomarkers for adjuvant therapy decision. BMC Gastroenterol 3:3–13. https://doi.org/10.1186/1471-230X-13-36

Article  CAS  Google Scholar 

Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23(10):2346–2357. https://doi.org/10.1200/jco.2005.00.240

Article  CAS  PubMed  Google Scholar 

Dwyer CJ, Arhontoulis DC, Rangel Rivera GO, Knochelmann HM, Smith AS, Wyatt MM, Rubinstein MP, Atkinson C, Thaxton JE, Neskey DM, Paulos CM (2020) Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells. Eur J Immunol 50(9):1386–1399. https://doi.org/10.1002/eji.201948455

Article  CAS  PubMed  PubMed Central  Google Scholar 

Egbuna C, Patrick-Iwuanyanwu KC, Onyeike EN, Uche CZ, Ogoke UP, Riaz M, Ibezim EN, Khan J, Adedokun KA, Imodoye SO, Bello IO (2023) Wnt/β-catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: molecular docking and ADMET study. Food Sci Nutr. https://doi.org/10.1002/fsn3.3405

Article  PubMed  PubMed Central